HOE 892

Known as: Butanoic acid, 4-((3,3a,4,5,6,6a-hexahydro-5-hydroxy-4-(3-hydroxy-1-octenyl)cyclopenta(b)pyrrol-2-yl)thio)-, methyl ester, (3aR-(3aalpha,4alpha(1E,3S*),5beta,6aalpha))-, HOE-892 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1984
1984
The effects of prostacyclin (PGI2) and its stable thia-thimo-analogue (Hoe 892) on gastric and intestinal secretions and gastric… (More)
Is this relevant?
1983
1983
The short chemical half-life limits the potential therapeutic value of Prostacyclin (PGI2). Replacement of the acid-labile… (More)
Is this relevant?